Screener
Design Therapeutics, Inc. DSGN Total Operating Expenses
Total Operating Expenses at other companies
Other financials
Where this comes from
Reported directly by Design Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingExpenses.
The source filing: Design Therapeutics, Inc.’s 10-Q, filed April 28, 2026.
- Filed
- Apr 28, 2026, 4:13 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-187063
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Operating expenses: | ||
| Research and development (including related party amounts of $72 and $228, respectively) | $14,379 | $15,377 |
| General and administrative (including related party amounts of $85 and $134, respectively) | 5,327 | 5,041 |
| Total operating expenses | 19,706 | 20,418 |
| Loss from operations | (19,706) | (20,418) |
| Interest income | 2,070 | 2,703 |
| Net loss | $(17,636) | $(17,715) |
| Net loss per share, basic and diluted | $(0.29) | $(0.31) |
Item 1. Financial Statements.
FAQ
- What is Design Therapeutics, Inc.'s total operating expenses?
- Design Therapeutics, Inc. (DSGN) reported total operating expenses of $19.71M in Q1 2026.
- How has Design Therapeutics, Inc.'s total operating expenses changed year-over-year?
- Design Therapeutics, Inc.'s total operating expenses decreased by 3.5% year-over-year, from $20.42M to $19.71M.
- What is the long-term trend for Design Therapeutics, Inc.'s total operating expenses?
- Over 4 years (2021 to 2025), Design Therapeutics, Inc.'s total operating expenses has grown at a 22.0% compound annual growth rate (CAGR), from $35.83M to $79.47M.
- What does total operating expenses mean?
- The sum of all operating costs including COGS, SG&A, R&D, D&A, and other operating charges. Revenue minus total operating expenses equals operating income.
Ask your AI about Design Therapeutics, Inc.'s total operating expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude